Different infusion durations for preventing platinumā€induced hearing loss in children with cancer

Source:
Cochrane Database of Systematic Reviews
Publisher:
Cochrane Database of Systematic Reviews
Publication date:
23 November 2016

Abstract

Since only one eligible RCT evaluating the use of a continuous cisplatin infusion versus a one-hour bolus cisplatin infusion was found, which had methodological limitations, no definitive conclusions can be made. More high quality research is needed.